Correlation Between EQRx and Prometheus Biosciences
Can any of the company-specific risk be diversified away by investing in both EQRx and Prometheus Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining EQRx and Prometheus Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between EQRx Inc and Prometheus Biosciences, you can compare the effects of market volatilities on EQRx and Prometheus Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in EQRx with a short position of Prometheus Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of EQRx and Prometheus Biosciences.
Diversification Opportunities for EQRx and Prometheus Biosciences
0.64 | Correlation Coefficient |
Poor diversification
The 3 months correlation between EQRx and Prometheus is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding EQRx Inc and Prometheus Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Prometheus Biosciences and EQRx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on EQRx Inc are associated (or correlated) with Prometheus Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Prometheus Biosciences has no effect on the direction of EQRx i.e., EQRx and Prometheus Biosciences go up and down completely randomly.
Pair Corralation between EQRx and Prometheus Biosciences
If you would invest 19,992 in Prometheus Biosciences on September 4, 2024 and sell it today you would earn a total of 0.00 from holding Prometheus Biosciences or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
EQRx Inc vs. Prometheus Biosciences
Performance |
| Timeline |
| EQRx Inc |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Prometheus Biosciences |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
EQRx and Prometheus Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with EQRx and Prometheus Biosciences
The main advantage of trading using opposite EQRx and Prometheus Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if EQRx position performs unexpectedly, Prometheus Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Prometheus Biosciences will offset losses from the drop in Prometheus Biosciences' long position.| EQRx vs. Century Therapeutics | EQRx vs. Edgewise Therapeutics | EQRx vs. C4 Therapeutics | EQRx vs. Mineralys Therapeutics, Common |
| Prometheus Biosciences vs. Apellis Pharmaceuticals | Prometheus Biosciences vs. Akero Therapeutics | Prometheus Biosciences vs. Immunovant | Prometheus Biosciences vs. Madrigal Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |